The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Actigraphy measured sleep disruption as a predictor of survival in advanced breast cancer.
Oxana Palesh
Research Funding - NCI
Arianna Aldridge Gerry
No relevant relationships to disclose
Jamie M. Zeitzer
No relevant relationships to disclose
Cheryl Koopman
No relevant relationships to disclose
Booil Jo
No relevant relationships to disclose
Eric Neri
No relevant relationships to disclose
Bita Nouriani
No relevant relationships to disclose
David Spiegel
No relevant relationships to disclose